|
G |
ABCA1 |
ATP binding cassette subfamily A member 1 |
multiple interactions |
ISO |
[Chitosan co-treated with Fish Oils] inhibits the reaction [Dietary Fats results in decreased expression of ABCA1 mRNA]; Chitosan inhibits the reaction [Dietary Fats results in decreased expression of ABCA1 mRNA] |
CTD |
PMID:28987369 |
|
NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases phosphorylation |
ISO EXP |
[Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of AKT1 protein] Chitosan results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:28732690 PMID:36706893 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
|
|
G |
ALAD |
aminolevulinate dehydratase |
multiple interactions |
ISO |
[Curcumin co-treated with Chitosan analog] inhibits the reaction [Arsenic results in decreased activity of ALAD protein] |
CTD |
PMID:22704994 |
|
NCBI chr 9:113,386,312...113,401,284
Ensembl chr 9:113,386,312...113,401,290
|
|
G |
ALPL |
alkaline phosphatase, biomineralization associated |
increases expression |
EXP |
Chitosan results in increased expression of ALPL mRNA; Chitosan results in increased expression of ALPL protein |
CTD |
PMID:25246786 |
|
NCBI chr 1:21,508,984...21,578,410
Ensembl chr 1:21,509,397...21,578,410
|
|
G |
AOX1 |
aldehyde oxidase 1 |
multiple interactions |
ISO |
[Chitosan co-treated with Fish Oils] inhibits the reaction [Dietary Fats results in decreased expression of AOX1 mRNA]; Chitosan inhibits the reaction [Dietary Fats results in decreased expression of AOX1 mRNA] |
CTD |
PMID:28987369 |
|
NCBI chr 2:200,586,014...200,682,241
Ensembl chr 2:200,586,014...200,677,064
|
|
G |
ARB2A |
ARB2 cotranscriptional regulator A |
multiple interactions increases expression |
EXP |
ARB2A protein affects the reaction [Chitosan results in decreased expression of CPE protein]; ARB2A protein affects the reaction [Chitosan results in decreased expression of MMP9 protein]; ARB2A protein affects the reaction [Chitosan results in decreased phosphorylation of MAPK1 protein]; ARB2A protein affects the reaction [Chitosan results in decreased phosphorylation of MAPK3 protein] Chitosan results in increased expression of ARB2A mRNA |
CTD |
PMID:36706893 |
|
NCBI chr 5:93,617,725...94,111,699
Ensembl chr 5:93,617,725...94,111,699
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
[Fluorouracil co-treated with Chitosan co-treated with polyaspartate] results in increased expression of BAX protein Chitosan analog inhibits the reaction [Doxorubicin results in increased expression of BAX protein] |
CTD |
PMID:18567086 PMID:30928397 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions |
ISO |
[Fluorouracil co-treated with Chitosan co-treated with polyaspartate] results in decreased expression of BCL2 protein [Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of BCL2 protein]; Chitosan analog inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] |
CTD |
PMID:18567086 PMID:28732690 PMID:30928397 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BGLAP |
bone gamma-carboxyglutamate protein |
increases expression |
EXP |
Chitosan results in increased expression of BGLAP mRNA |
CTD |
PMID:25246786 |
|
NCBI chr 1:156,242,184...156,243,317
Ensembl chr 1:156,242,184...156,243,317
|
|
G |
CASP3 |
caspase 3 |
multiple interactions |
EXP ISO |
Chitosan metabolite inhibits the reaction [Copper results in increased activity of CASP3 protein] Chitosan analog inhibits the reaction [Doxorubicin results in increased expression of CASP3 protein]; Chitosan inhibits the reaction [carbendazim results in increased expression of CASP3 protein] |
CTD |
PMID:25542178 PMID:30928397 PMID:35705592 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP9 |
caspase 9 |
multiple interactions |
ISO |
Chitosan analog inhibits the reaction [Doxorubicin results in increased expression of CASP9 protein] |
CTD |
PMID:30928397 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
multiple interactions |
ISO |
[Chitosan analog co-treated with Quercetin] inhibits the reaction [ochratoxin A results in decreased activity of CAT protein]; [Curcumin co-treated with Chitosan analog] inhibits the reaction [Arsenic results in decreased activity of CAT protein]; Chitosan analog inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; Chitosan analog inhibits the reaction [ochratoxin A results in decreased activity of CAT protein]; Chitosan inhibits the reaction [carbendazim results in decreased expression of CAT protein]; Chitosan inhibits the reaction [Carbon Tetrachloride results in decreased activity of CAT protein] |
CTD |
PMID:12679053 PMID:22704994 PMID:27923682 PMID:30928397 PMID:35705592 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CLEC7A |
C-type lectin domain containing 7A |
multiple interactions decreases expression |
EXP |
Chitosan inhibits the reaction [Lipopolysaccharides results in decreased expression of CLEC7A mRNA] Chitosan results in decreased expression of CLEC7A mRNA |
CTD |
PMID:21329777 |
|
NCBI chr12:10,116,777...10,130,304
Ensembl chr12:10,116,777...10,130,258
|
|
G |
COL15A1 |
collagen type XV alpha 1 chain |
decreases expression |
EXP |
Chitosan results in decreased expression of COL15A1 mRNA |
CTD |
PMID:36706893 |
|
NCBI chr 9:98,943,907...99,070,787
Ensembl chr 9:98,943,179...99,070,787
|
|
G |
CPE |
carboxypeptidase E |
multiple interactions decreases expression |
EXP |
ARB2A protein affects the reaction [Chitosan results in decreased expression of CPE protein] Chitosan results in decreased expression of CPE mRNA; Chitosan results in decreased expression of CPE protein |
CTD |
PMID:36706893 |
|
NCBI chr 4:165,379,008...165,498,547
Ensembl chr 4:165,361,194...165,498,547
|
|
G |
CTNNB1 |
catenin beta 1 |
multiple interactions |
ISO |
[Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of CTNNB1 protein] |
CTD |
PMID:28732690 |
|
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
|
|
G |
CYP3A4 |
cytochrome P450 family 3 subfamily A member 4 |
increases activity |
EXP |
Chitosan analog results in increased activity of CYP3A4 protein |
CTD |
PMID:20831879 |
|
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
|
|
G |
CYP7A1 |
cytochrome P450 family 7 subfamily A member 1 |
multiple interactions |
ISO |
Chitosan inhibits the reaction [Dietary Fats results in increased expression of CYP7A1 mRNA]; Fish Oils promotes the reaction [Chitosan inhibits the reaction [Dietary Fats results in increased expression of CYP7A1 mRNA]] |
CTD |
PMID:28987369 |
|
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
|
|
G |
DKK1 |
dickkopf WNT signaling pathway inhibitor 1 |
increases expression |
EXP |
Chitosan results in increased expression of DKK1 mRNA |
CTD |
PMID:36706893 |
|
NCBI chr10:52,314,281...52,317,657
Ensembl chr10:52,314,281...52,318,042
|
|
G |
FABP4 |
fatty acid binding protein 4 |
multiple interactions |
ISO |
[Fish Oils co-treated with Chitosan] inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA]; Chitosan inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA] |
CTD |
PMID:28987369 |
|
NCBI chr 8:81,478,419...81,483,233
Ensembl chr 8:81,478,419...81,483,236
|
|
G |
FASN |
fatty acid synthase |
multiple interactions |
ISO |
[Fish Oils co-treated with Chitosan] inhibits the reaction [Dietary Fats results in increased expression of FASN mRNA]; Chitosan inhibits the reaction [Dietary Fats results in increased expression of FASN mRNA] |
CTD |
PMID:28987369 |
|
NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
|
|
G |
FOXO3 |
forkhead box O3 |
decreases phosphorylation |
EXP |
Chitosan results in decreased phosphorylation of FOXO3 protein |
CTD |
PMID:36706893 |
|
NCBI chr 6:108,559,825...108,684,774
Ensembl chr 6:108,559,835...108,684,774
|
|
G |
GCG |
glucagon |
increases expression increases secretion multiple interactions |
EXP |
Chitosan results in increased expression of GCG mRNA Chitosan results in increased secretion of GCG protein SB 203580 inhibits the reaction [Chitosan results in increased expression of GCG mRNA]; SB 203580 inhibits the reaction [Chitosan results in increased secretion of GCG protein] |
CTD |
PMID:23611362 |
|
NCBI chr 2:162,142,882...162,152,247
Ensembl chr 2:162,142,882...162,152,404
|
|
G |
GOT1 |
glutamic-oxaloacetic transaminase 1 |
multiple interactions |
ISO |
Chitosan inhibits the reaction [carbendazim results in increased secretion of GOT1 protein] |
CTD |
PMID:35705592 |
|
NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624
|
|
G |
GPT |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
Chitosan inhibits the reaction [carbendazim results in increased secretion of GPT protein] |
CTD |
PMID:35705592 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
GPX1 |
glutathione peroxidase 1 |
multiple interactions increases expression |
ISO |
[Chitosan analog co-treated with Quercetin] inhibits the reaction [ochratoxin A results in decreased expression of GPX1 mRNA]; [Chitosan analog co-treated with Quercetin] results in increased expression of GPX1 mRNA; Chitosan analog inhibits the reaction [ochratoxin A results in decreased expression of GPX1 mRNA] Chitosan analog results in increased expression of GPX1 mRNA |
CTD |
PMID:27923682 |
|
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
|
|
G |
GSK3B |
glycogen synthase kinase 3 beta |
multiple interactions |
ISO |
[Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of GSK3B protein] |
CTD |
PMID:28732690 |
|
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
|
|
G |
GSR |
glutathione-disulfide reductase |
multiple interactions |
ISO |
Chitosan analog inhibits the reaction [Doxorubicin results in decreased expression of GSR mRNA] |
CTD |
PMID:30928397 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
HMGCR |
3-hydroxy-3-methylglutaryl-CoA reductase |
multiple interactions |
ISO |
[Fish Oils co-treated with Chitosan] inhibits the reaction [Dietary Fats results in increased expression of HMGCR mRNA]; Chitosan inhibits the reaction [Dietary Fats results in increased expression of HMGCR mRNA] |
CTD |
PMID:28987369 |
|
NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions |
EXP ISO |
[Chitosan metabolite results in decreased susceptibility to Copper] which results in increased expression of HMOX1 mRNA; [Chitosan metabolite results in decreased susceptibility to Copper] which results in increased expression of HMOX1 protein Chitosan analog inhibits the reaction [Doxorubicin results in decreased expression of HMOX1 mRNA]; Chitosan inhibits the reaction [carbendazim results in decreased expression of HMOX1 mRNA] |
CTD |
PMID:25542178 PMID:30928397 PMID:35705592 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
IL10 |
interleukin 10 |
multiple interactions increases secretion |
EXP |
Chitosan inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein] Chitosan results in increased secretion of IL10 protein |
CTD |
PMID:21329777 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL6 |
interleukin 6 |
increases secretion multiple interactions |
EXP |
Chitosan results in increased secretion of IL6 protein Chitosan inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] |
CTD |
PMID:21329777 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
KEAP1 |
kelch like ECH associated protein 1 |
multiple interactions |
ISO |
Chitosan inhibits the reaction [carbendazim results in increased expression of KEAP1 mRNA] |
CTD |
PMID:35705592 |
|
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
decreases phosphorylation multiple interactions |
EXP |
Chitosan results in decreased phosphorylation of MAPK1 protein ARB2A protein affects the reaction [Chitosan results in decreased phosphorylation of MAPK1 protein] |
CTD |
PMID:36706893 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions decreases phosphorylation |
ISO EXP |
[Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of MAPK3 protein] Chitosan results in decreased phosphorylation of MAPK3 protein ARB2A protein affects the reaction [Chitosan results in decreased phosphorylation of MAPK3 protein] |
CTD |
PMID:28732690 PMID:36706893 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
multiple interactions |
ISO |
Chitosan inhibits the reaction [Aminolevulinic Acid analog results in increased activity of MMP2 protein] |
CTD |
PMID:18806744 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
decreases expression multiple interactions |
EXP |
Chitosan results in decreased expression of MMP9 mRNA; Chitosan results in decreased expression of MMP9 protein ARB2A protein affects the reaction [Chitosan results in decreased expression of MMP9 protein] |
CTD |
PMID:36706893 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions affects localization |
EXP ISO |
[Chitosan metabolite results in decreased susceptibility to Copper] which results in increased phosphorylation of NFE2L2 protein Chitosan analog affects the localization of NFE2L2 protein Chitosan analog inhibits the reaction [Doxorubicin affects the localization of NFE2L2 protein]; Chitosan inhibits the reaction [carbendazim results in decreased expression of NFE2L2 mRNA]; pyrazolanthrone inhibits the reaction [Chitosan analog inhibits the reaction [Doxorubicin affects the localization of NFE2L2 protein]]; SB 203580 inhibits the reaction [Chitosan analog inhibits the reaction [Doxorubicin affects the localization of NFE2L2 protein]] |
CTD |
PMID:25542178 PMID:30928397 PMID:35705592 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
Chitosan inhibits the reaction [carbendazim results in increased expression of NOS2 protein] |
CTD |
PMID:35705592 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
ISO |
Chitosan analog inhibits the reaction [Doxorubicin results in decreased expression of NQO1 mRNA] |
CTD |
PMID:30928397 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
NR1H3 |
nuclear receptor subfamily 1 group H member 3 |
multiple interactions |
ISO |
[Chitosan co-treated with Fish Oils] inhibits the reaction [Dietary Fats results in increased expression of NR1H3 protein] |
CTD |
PMID:28987369 |
|
NCBI chr11:47,248,300...47,269,033
Ensembl chr11:47,248,300...47,269,033
|
|
G |
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
decreases phosphorylation |
EXP |
Chitosan results in decreased phosphorylation of PIK3CA protein |
CTD |
PMID:36706893 |
|
NCBI chr 3:179,148,126...179,240,093
Ensembl chr 3:179,148,114...179,240,093
|
|
G |
PIK3R1 |
phosphoinositide-3-kinase regulatory subunit 1 |
decreases phosphorylation |
EXP |
Chitosan results in decreased phosphorylation of PIK3R1 protein |
CTD |
PMID:36706893 |
|
NCBI chr 5:68,215,756...68,301,821
Ensembl chr 5:68,215,740...68,301,821
|
|
G |
PPARA |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
[Chitosan co-treated with Fish Oils] inhibits the reaction [Dietary Fats results in decreased expression of PPARA protein] |
CTD |
PMID:28987369 |
|
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
|
|
G |
PPARGC1A |
PPARG coactivator 1 alpha |
increases expression |
EXP |
Chitosan results in increased expression of PPARGC1A mRNA |
CTD |
PMID:36706893 |
|
NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
[Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of RELA protein] |
CTD |
PMID:28732690 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
RUNX2 |
RUNX family transcription factor 2 |
increases expression |
EXP |
Chitosan results in increased expression of RUNX2 mRNA; Chitosan results in increased expression of RUNX2 protein |
CTD |
PMID:25246786 |
|
NCBI chr 6:45,328,330...45,551,082
Ensembl chr 6:45,328,157...45,664,349
|
|
G |
SOD1 |
superoxide dismutase 1 |
increases expression multiple interactions |
ISO |
Chitosan analog results in increased expression of SOD1 mRNA [Chitosan analog co-treated with Quercetin] results in increased expression of SOD1 mRNA; Chitosan analog inhibits the reaction [Doxorubicin results in decreased expression of SOD1 mRNA] |
CTD |
PMID:27923682 PMID:30928397 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
|
|
G |
SPARCL1 |
SPARC like 1 |
decreases expression |
EXP |
Chitosan results in decreased expression of SPARCL1 mRNA |
CTD |
PMID:36706893 |
|
NCBI chr 4:87,473,335...87,529,376
Ensembl chr 4:87,473,335...87,531,061
|
|
G |
SPP1 |
secreted phosphoprotein 1 |
increases expression |
EXP |
Chitosan results in increased expression of SPP1 mRNA |
CTD |
PMID:25246786 |
|
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
|
|
G |
SREBF1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions |
ISO |
[Fish Oils co-treated with Chitosan] inhibits the reaction [Dietary Fats results in increased expression of SREBF1 mRNA]; Chitosan inhibits the reaction [Dietary Fats results in increased expression of SREBF1 mRNA] |
CTD |
PMID:28987369 |
|
NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
|
|
G |
TH |
tyrosine hydroxylase |
multiple interactions |
ISO |
[Curcumin co-treated with Chitosan analog] inhibits the reaction [Arsenic results in decreased expression of TH protein] |
CTD |
PMID:22704994 |
|
NCBI chr11:2,163,929...2,171,815
Ensembl chr11:2,163,929...2,171,815
|
|
G |
TLR2 |
toll like receptor 2 |
multiple interactions decreases expression |
EXP |
Chitosan inhibits the reaction [Lipopolysaccharides results in decreased expression of TLR2 mRNA] Chitosan results in decreased expression of TLR2 mRNA |
CTD |
PMID:21329777 |
|
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,706,260
|
|
G |
TLR4 |
toll like receptor 4 |
decreases expression multiple interactions |
EXP |
Chitosan results in decreased expression of TLR4 mRNA Chitosan inhibits the reaction [Lipopolysaccharides results in decreased expression of TLR4 mRNA] |
CTD |
PMID:21329777 |
|
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions increases secretion |
EXP |
Chitosan inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] Chitosan results in increased secretion of TNF protein |
CTD |
PMID:21329777 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TPH1 |
tryptophan hydroxylase 1 |
multiple interactions |
ISO |
[Curcumin co-treated with Chitosan analog] inhibits the reaction [Arsenic results in decreased expression of TPH1 protein] |
CTD |
PMID:22704994 |
|
NCBI chr11:18,017,555...18,046,269
Ensembl chr11:18,017,555...18,046,269
|
|